☆ 4.6 Article

Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (′CUPID′ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of- concept trial

BMJ OPEN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment

Angela L. D'Rozario et al.

Summary: This study evaluated the effect of continuous positive airway pressure (CPAP) treatment on cognitive function and sleep electroencephalogram (EEG) in patients with obstructive sleep apnea (OSA). The results showed that after 6 months of CPAP treatment, cognitive function improved and sleep EEG features were enhanced. These findings suggest that the cognitive deficits and altered brain electrophysiology observed in untreated OSA can be reversed with treatment.

SLEEP (2022)

添加到收藏夹

Article Biochemical Research Methods

Orally administered cannabidiol does not produce false-positive tests for Δ9-tetrahydrocannabinol on the Securetec DrugWipe® 5S or Drager DrugTest® 5000

Danielle McCartney et al.

Summary: Orally administered CBD does not produce false-positive tests for THC on standard oral fluid testing devices, indicating a low likelihood of individuals using CBD-only products being falsely accused of driving under the influence of cannabis.

DRUG TESTING AND ANALYSIS (2022)

添加到收藏夹

Article Clinical Neurology

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial

Danielle McCartney et al.

Summary: This study investigated the effects of acute, oral CBD treatment on driving performance and found that it did not impair cognitive function or driving performance, and did not induce feelings of intoxication.

JOURNAL OF PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Sport Sciences

Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial

Ayshe Sahinovic et al.

Summary: This pilot study investigated the effects of acute, oral CBD treatment on physiological and psychological responses to aerobic exercise. The results suggested that CBD may increase oxygen uptake, pleasure ratings, and lactate concentrations during exercise, while reducing endogenous cannabinoid concentrations. The study suggests that CBD may alter some key physiological and psychological responses to exercise without impairing performance. Larger studies are needed to confirm and further understand these preliminary findings.

SPORTS MEDICINE-OPEN (2022)

添加到收藏夹

Article Biochemical Research Methods

A validated method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial

Richard C. Kevin et al.

Summary: In this study, a method for the simultaneous quantification of CBD, THC and their major Phase I metabolites was developed, optimized and validated according to FDA guidelines. The method is accurate, reproducible, sensitive, and can be carried out in high-throughput 96-well formats for larger scale clinical trials. Deuterated internal standards were crucial to account for variable matrix effects between plasma lots. The application of the method to plasma samples from individuals undergoing oral CBD treatment in an open-label trial of CBD effects in anxiety disorders demonstrated its immediate utility for ongoing and upcoming clinical trials, with potential to accommodate additional metabolites as analytical reference materials become commercially available.

DRUG TESTING AND ANALYSIS (2021)

添加到收藏夹

Review Behavioral Sciences

Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review

Danielle McCartney et al.

Summary: The study found that cannabis has acute effects on driving performance and related cognitive skills, with some measures showing impairment. Long-term cannabis users experienced less impairment compared to other users, and factors such as ingestion method, dosage, and time affected the duration of Delta(9)-THC's effects. The recommendations suggest waiting at least 5 hours after inhaling cannabis before engaging in safety-sensitive tasks.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

添加到收藏夹

Article Clinical Neurology

The social and economic cost of sleep disorders

Jared Streatfeild et al.

Summary: The study estimated the economic cost of common sleep disorders in Australia for 2019-2020, with a total cost of $35.4 billion, of which financial costs accounted for $10.0 billion and nonfinancial costs accounted for $25.4 billion. The results suggest that the economic costs associated with sleep disorders are substantial, with the financial component equivalent to 0.73% of Australian gross domestic product.

SLEEP (2021)

添加到收藏夹

Article Clinical Neurology

Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo

Jennifer H. Walsh et al.

Summary: This study showed that nightly sublingual administration of a cannabinoid extract (ZTL-101) for 2 weeks is well tolerated and improves insomnia symptoms and sleep quality in individuals with chronic insomnia symptoms.

SLEEP (2021)

添加到收藏夹

Article Clinical Neurology

The social and economic cost of sleep disorders

Jared Streatfeild et al.

Summary: The study estimated the economic cost of common sleep disorders in Australia for 2019-2020, totaling $35.4 billion, with obstructive sleep apnea, insomnia, and restless legs syndrome being the main contributors. Financial costs accounted for $10.0 billion, equivalent to 0.73% of Australian GDP, while the nonfinancial cost was $25.4 billion, representing 3.2% of total Australian burden of disease. The study suggests greater expenditure on detection, treatment, and prevention of sleep disorders is warranted.

SLEEP (2021)

添加到收藏夹

Article Clinical Neurology

Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo

Jennifer H. Walsh et al.

Summary: The study showed that nightly sublingual administration of cannabinoid extract (ZTL-101) for 2 weeks was well tolerated and improved insomnia symptoms and sleep quality in individuals with chronic insomnia symptoms.

SLEEP (2021)

添加到收藏夹

Review Neurosciences

Sleep, insomnia, and depression

Dieter Riemann et al.

NEUROPSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

Anastasia Suraev et al.

BMJ OPEN (2020)

添加到收藏夹

Review Neurosciences

Cannabinoids, Endocannabinoids and Sleep

Andrew J. Kesner et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

添加到收藏夹

Article Medicine, General & Internal

Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years

Charles M. Morin et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Substance Abuse

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

Nicholas Lintzeris et al.

HARM REDUCTION JOURNAL (2020)

添加到收藏夹

Article Neurosciences

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

Thomas R. Arkell et al.

PSYCHOPHARMACOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Mobile Telephone Use and Reaction Time in Drivers With Glaucoma

Nara G. Ogata et al.

JAMA NETWORK OPEN (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

Shenglong Zou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Review Health Care Sciences & Services

Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review

Erin Koffel et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2018)

添加到收藏夹

Article Psychology, Clinical

The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis

Simon F. Crowe et al.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Prevalence and comorbidity of sleep conditions in Australian adults: 2016 Sleep Health Foundation national survey

Sarah L. Appleton et al.

SLEEP HEALTH (2018)

添加到收藏夹

Article Toxicology

Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal

Richard C. Kevin et al.

FORENSIC TOXICOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

Carrol Gamble et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Review Neurosciences

An Introduction to the Endogenous Cannabinoid System

Hui-Chen Lu et al.

BIOLOGICAL PSYCHIATRY (2016)

添加到收藏夹

Review Psychiatry

Insomnia and risk of dementia in older adults: Systematic review and meta-analysis

Katie Moraes de Almondes et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2016)

添加到收藏夹

Article Orthopedics

The Brazilian Portuguese version of the revised Maastricht Upper Extremity Questionnaire (MUEQ-Br revised): translation, cross-cultural adaptation, reliability, and structural validation

Aline Mendonca Turci et al.

BMC MUSCULOSKELETAL DISORDERS (2015)

添加到收藏夹

Review Medicine, General & Internal

Cannabinoids for Medical Use A Systematic Review and Meta-analysis

Penny F. Whiting et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

添加到收藏夹

Editorial Material Clinical Neurology

AASM Scoring Manual Version 2.2 Updates: New Chapters for Scoring Infant Sleep Staging and Home Sleep Apnea Testing

Richard B. Berry et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2015)

添加到收藏夹

Article Clinical Neurology

An automated algorithm to identify and reject artefacts for quantitative EEG analysis during sleep in patients with sleep-disordered breathing

Angela L. D'Rozario et al.

SLEEP AND BREATHING (2015)

添加到收藏夹

Article Medicine, General & Internal

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

An-Wen Chan et al.

ANNALS OF INTERNAL MEDICINE (2013)

添加到收藏夹

Article Clinical Neurology

Construction and validation of the EEG analogues of the Karolinska sleepiness scale based on the Karolinska drowsiness test

Arcady A. Putilov et al.

CLINICAL NEUROPHYSIOLOGY (2013)

添加到收藏夹

Article Clinical Neurology

Predictors of Treatment Response to Brief Behavioral Treatment of Insomnia (BBTI) in Older Adults

Wendy M. Troxel et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2013)

添加到收藏夹

Article Neurosciences

The drug effects questionnaire: psychometric support across three drug types

Meghan E. Morean et al.

PSYCHOPHARMACOLOGY (2013)

添加到收藏夹

Review Clinical Neurology

Adherence to cognitive behavioral therapy for insomnia: A systematic review

Ellyn E. Matthews et al.

SLEEP MEDICINE REVIEWS (2013)

添加到收藏夹

Article Engineering, Aerospace

Validity and sensitivity of a brief psychomotor vigilance test (PVT-B) to total and partial sleep deprivation

Mathias Basner et al.

ACTA ASTRONAUTICA (2011)

添加到收藏夹

Review Critical Care Medicine

Aging and Sleep: Physiology and Pathophysiology

Bradley A. Edwards et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

添加到收藏夹

Article Neurosciences

Cannabinoids and hamster circadian activity rhythms

Anna E. Sanford et al.

BRAIN RESEARCH (2008)

添加到收藏夹

Review Clinical Neurology

The role of the CB1 receptor in the regulation of sleep

Eric Murillo-Rodriguez

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

Human cannabinoid pharmacokinetics

Marilyn A. Huestis

CHEMISTRY & BIODIVERSITY (2007)

添加到收藏夹

Article Neurosciences

Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor

E Murillo-Rodríguez et al.

NEUROREPORT (2001)

添加到收藏夹

Article Clinical Neurology

Validation of the Insomnia Severity Index as an outcome measure for insomnia research

Celyne H. Bastien et al.

SLEEP MEDICINE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.